Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants (LAIF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01413581
Recruitment Status : Terminated (Primary endpoint showed no stat significant difference. FU > M12 terminated.)
First Posted : August 10, 2011
Last Update Posted : July 30, 2015
Information provided by (Responsible Party):
Swedish Orphan Biovitrum